Patient Capital Management, LLC — CITIGROUP INC C: Quarterly 13F Position History
Patient Capital Management, LLC has reported CITIGROUP INC (C) on 17 13F-HR filings in Pactolio's tracked window, first appearing in Q1 2022. As of Q1 2026, the position is sized at 1,413,870 shares ($160.3M market value, 5.98% of the equity book). Quarter-over-quarter share count change: + 122,076 (+9.5%) .
- 1,413,870Shares Held (Latest Filing)
- $160.3MReported Market Value (Latest Filing)
- 5.98%Portfolio Weight (% of 13F Equity Book)
- +122,076Quarter-over-Quarter Share Change
- +$9.6MQuarter-over-Quarter Value Change
- 1,889,331Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 17 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 1,413,870 | +122,076 | +9.5% | $160.3M | 5.98% | $113.41 |
| Q4 2025 | 1,291,794 | 18,613 | -1.4% | $150.7M | 5.82% | $116.69 |
| Q3 2025 | 1,310,407 | 35,310 | -2.6% | $133.0M | 5.32% | $101.50 |
| Q2 2025 | 1,345,717 | 59,348 | -4.2% | $114.5M | 5.17% | $85.12 |
| Q1 2025 | 1,405,065 | 136,243 | -8.8% | $99.7M | 5.13% | $70.99 |
| Q4 2024 | 1,541,308 | 550 | -0.0% | $108.5M | 5.01% | $70.39 |
| Q3 2024 | 1,541,858 | 121,252 | -7.3% | $96.5M | 4.74% | $62.60 |
| Q2 2024 | 1,663,110 | 113,965 | -6.4% | $105.5M | 5.61% | $63.46 |
| Q1 2024 | 1,777,075 | 112,256 | -5.9% | $112.4M | 5.47% | $63.24 |
| Q4 2023 | 1,889,331 | +6,902 | +0.4% | $97.2M | 5.15% | $51.44 |
| Q3 2023 | 1,882,429 | +376,413 | +25.0% | $77.4M | 4.54% | $41.13 |
| Q2 2023 | 1,506,016 | +1,357,616 | +914.8% | $69.3M | 3.86% | $46.04 |
| Q1 2023 | 148,400 | +12,600 | +9.3% | $7.0M | 3.10% | $46.89 |
| Q4 2022 | 135,800 | 0 | — | $6.1M | 3.01% | $45.23 |
| Q3 2022 | 135,800 | 0 | — | $5.7M | 2.87% | $41.67 |
| Q2 2022 | 135,800 | +31,800 | +30.6% | $6.2M | 3.04% | $45.99 |
| Q1 2022 | 104,000 | — | — | $5.6M | 2.18% | $53.40 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Patient Capital Management, LLC first disclose a C position in 13F-HR filings?
Patient Capital Management, LLC first reported CITIGROUP INC (C) on its 13F-HR filing for the period ending 2022-03-31 (Q1 2022). The position has appeared on 17 reported quarters within Pactolio's tracked window.
What was Patient Capital Management, LLC's most recent quarter-over-quarter share-count change in C?
Between Q4 2025 and Q1 2026, Patient Capital Management, LLC added 122,076 shares of C (+9.5%), bringing the total reported position to 1,413,870 shares at a market value of $160.3M.
Does the implied price-per-share represent Patient Capital Management, LLC's cost basis in C?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.